Form D · Pharmaceuticals
HAR-KCY, LLC
Los Angeles, CA · CIK 0001690804
Offering snapshot reported Dec 2, 2016 · SEC filing
- Reported sold
- $3.01M Offering amount: $3.01M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $601K Reported outside-investor minimum
- First sale
- Nov 17, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 2, 2016 | Initial | $3,005,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-275534
No sales commissions or finders' fee expenses.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Dec 2, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Harvey A Bookstein | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11766 Wilshire Boulevard, 9 Th Floor
Los Angeles, CA, 90025
Los Angeles, CA, 90025